{"transactions":[{"id":923406,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":68066,"kind":"person","name":"Dissanaike Sharmila","position":1,"cik":"0001885069","reported_name":"Dissanaike Sharmila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-03T15:00:04.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":53960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on January 30, 2027. Each restricted stock unit represents a contigent right to receive one share of common stock."}],"balance_after":53960,"source":{"system":"sec-edgar","filing":"0001193125-26-034626","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034626/ownership.xml","form_type":"4"}},{"id":1286302,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":68066,"kind":"person","name":"Dissanaike Sharmila","position":1,"cik":"0001885069","reported_name":"Dissanaike Sharmila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T22:34:12.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":35900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":35900,"derivative":{"exercise_price":1.7,"expiration_date":"2035-01-31","underlying":"Common Stock","underlying_shares":35900},"source":{"system":"sec-edgar","filing":"0000950170-25-013770","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025013770/ownership.xml","form_type":"4/A","original_submission_date":"2025-02-03"}},{"id":1286301,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":68066,"kind":"person","name":"Dissanaike Sharmila","position":1,"cik":"0001885069","reported_name":"Dissanaike Sharmila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-04T22:34:12.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":17950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on January 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":87180,"source":{"system":"sec-edgar","filing":"0000950170-25-013770","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025013770/ownership.xml","form_type":"4/A","original_submission_date":"2025-02-03"}},{"id":1288407,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":68066,"kind":"person","name":"Dissanaike Sharmila","position":1,"cik":"0001885069","reported_name":"Dissanaike Sharmila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-03T16:48:34.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":35900,"price":1.73,"value":62107.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":35900,"derivative":{"exercise_price":1.73,"expiration_date":"2035-01-30","underlying":"Common Stock","underlying_shares":35900},"source":{"system":"sec-edgar","filing":"0000950170-25-012107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025012107/ownership.xml","form_type":"4"}},{"id":1288406,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":68066,"kind":"person","name":"Dissanaike Sharmila","position":1,"cik":"0001885069","reported_name":"Dissanaike Sharmila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-03T16:48:34.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":17950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on January 30, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":87180,"source":{"system":"sec-edgar","filing":"0000950170-25-012107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025012107/ownership.xml","form_type":"4"}},{"id":1675834,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":68066,"kind":"person","name":"Dissanaike Sharmila","position":1,"cik":"0001885069","reported_name":"Dissanaike Sharmila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-20T02:02:44.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":83685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":83685,"derivative":{"exercise_price":2.09,"expiration_date":"2034-01-19","underlying":"Common Stock","underlying_shares":83685},"source":{"system":"sec-edgar","filing":"0001209191-24-001978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919124001978/doc4.xml","form_type":"4"}},{"id":1675833,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":68066,"kind":"person","name":"Dissanaike Sharmila","position":1,"cik":"0001885069","reported_name":"Dissanaike Sharmila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-20T02:02:44.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":13948,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on January 19, 2025."}],"balance_after":69230,"source":{"system":"sec-edgar","filing":"0001209191-24-001978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919124001978/doc4.xml","form_type":"4"}},{"id":2080345,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":68066,"kind":"person","name":"Dissanaike Sharmila","position":1,"cik":"0001885069","reported_name":"Dissanaike Sharmila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-20T22:20:18.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":77160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":77160,"derivative":{"exercise_price":2.74,"expiration_date":"2032-12-16","underlying":"Common Stock","underlying_shares":77160},"source":{"system":"sec-edgar","filing":"0001209191-22-062187","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122062187/doc4.xml","form_type":"4"}},{"id":2080344,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":68066,"kind":"person","name":"Dissanaike Sharmila","position":1,"cik":"0001885069","reported_name":"Dissanaike Sharmila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-20T22:20:18.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":38580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on December 16, 2023."}],"balance_after":55282,"source":{"system":"sec-edgar","filing":"0001209191-22-062187","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122062187/doc4.xml","form_type":"4"}},{"id":2460246,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":68066,"kind":"person","name":"Dissanaike Sharmila","position":1,"cik":"0001885069","reported_name":"Dissanaike Sharmila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-23T23:56:24.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":20903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":20903,"derivative":{"exercise_price":9.81,"expiration_date":"2031-12-22","underlying":"Common Stock","underlying_shares":20903},"source":{"system":"sec-edgar","filing":"0001209191-21-071168","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121071168/doc4.xml","form_type":"4"}},{"id":2460245,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":68066,"kind":"person","name":"Dissanaike Sharmila","position":1,"cik":"0001885069","reported_name":"Dissanaike Sharmila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-23T23:56:24.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":10452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on December 22, 2022."}],"balance_after":16702,"source":{"system":"sec-edgar","filing":"0001209191-21-071168","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121071168/doc4.xml","form_type":"4"}}]}